Hydrix Limited · ASX:HYD

Hydrix — Investor Presentation (November 2019)

13 slides from Hydrix's investor presentation, Nov 4, 2019

  1. Slide 1: Hydrix Limited Capital Raising Presentation

    For personal use only Hydrix Limited Hydrix brings technologies to life which enhance people’s health, safety and well-being Capital Raising Presentation 4 November 2019 ASX Release Page 1 Hydrix Ltd | Capital Raising Presentation | 4 November 2019

  2. Slide 2: Investment Highlights – Continued Growth & Value Creation

    Investment Highlights – Continued Growth & Value Creation For personal use only • Growing global demand for Hydrix’s engineering, regulatory & design services – built over a 15+ year track record – Recognised sector expertise in: Medical Technology, Consumer & Industrial and Defense & Aerospace 1.)

  3. Slide 3: Hydrix – a corporate snapshot

    Hydrix – a corporate snapshot For personal use only Major Shareholders1 Shares (m) % Capital Structure (post transaction) John W King Nominees & Associates 166.8 24.9% Ticker HYD Flet Superannuation Pty Ltd 31.9 4.8% Share Price2 $0.032 Kurrawonga Pty Ltd 19.4 2.9% Shares on Issue (m)3 755.3 BNP Par

  4. Slide 4: Hydrix unique value proposition is developing technologies that solve complex problems

    Hydrix unique value proposition is developing technologies that solve complex problems For personal use only Our core areas of expertise are within large addressable, global, high growth sectors Medical Technology Defence & Aerospace Selection of our Clients • Cardiology • Simulation & training • Ne

  5. Slide 5: Funding Package - Overview

    Funding Package - Overview For personal use only Completed Placement & Debt Facility with a Share Purchase Plan to be offered to eligible shareholders • Completed A$2.5m Placement to sophisticated and professional investors via the issue of 86 million fully paid ordinary shares (‘Placement’) • The P

  6. Slide 6: Funding Package - driving profitable growth

    Funding Package - driving profitable growth For personal use only • Funding package strengthens the Company’s balance sheet and allows Indicative Timetable the Company to execute on its growth strategy, repay existing shareholder loans (on equal or better terms) whilst minimising dilution to existin

  7. Slide 7: Global Experts in three large and growing sectors

    Global Experts in three large and growing sectors For personal use only 1. Medical Technology 2. Consumer & Industrials 3. Defence & Aerospace Micro-X IoT Water Management Thomas Global Systems The key development partner in Hydrix selected after global Hydrix partnered with Thomas the first carbon

  8. Slide 8: All milestones were exceeded during FY19

    All milestones were exceeded during FY19 For personal use only Milestones - FY19 Achievements Minimum 15% revenue growth over Exceeded each half year growth target by over two times Exceeded → prior half year period Full year revenue growth of 149% (FY19: $14.23m, FY18: $5.7m) 15% increase in engine

  9. Slide 9: Continuing to drive growth though new and existing revenue streams

    Continuing to drive growth though new and existing revenue streams For personal use only Financial Progress FY20 Milestones • 149% FY19 revenue growth (FY19: $14.23m, FY18: $5.7m) • Revenue growth to exceed 15%+ over FY19 • Delivered 4Q19 maiden quarterly cash operating profit of $0.43m1 • Deliver a

  10. Slide 10: Meaningful progress implementing Buy, Build & Invest strategy

    Meaningful progress implementing Buy, Build & Invest strategy For personal use only Accessing valuable early stage tech and leveraging design, engineering and commercialisation capabilities Buy, Build, & Invest strategy progress since acquiring Hydrix Announced 2 Oct 19 Capital Gains Value driven fr

  11. Slide 11: Angel Medical Systems (AngelMed) – Guardian device

    Angel Medical Systems (AngelMed) – Guardian® device For personal use only • Guardian® is the world’s first FDA (PMA) approved implantable cardiac monitor and patient alerting system • Guardian® uses AI machine learning based algorithms to accurately detect changes to the heart-beat indicative of a p

  12. Slide 12: Disclaimer

    Disclaimer For personal use only This presentation has been prepared by Hydrix Limited (the “Company” or “Hydrix”). This presentation is being provided to investors for the sole purpose of providing preliminary background financial and other information to enable recipients to review the business ac

  13. Slide 13: For personal use only

    For personal use only hydrix.com 30-32 Compark Circuit Mulgrave VIC 3170 Australia ASX:HYD Page 13 Hydrix Ltd | Capital Raising Presentation | 4 November 2019

Hydrix — Investor Presentation (November 2019) on 6ix